Read + Share
Hayashi K, Furuta M, Furusawa K, Hamaguchi T, et al. Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments
After Third-line Nivolumab for Advanced Gastric Cancer. Anticancer Res 2023;43:2831-2840.
PMID: 37247885
|
 |
|
Hayashi K, Furuta M, Furusawa K, Hamaguchi T, et al. Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments
After Third-line Nivolumab for Advanced Gastric Cancer. Anticancer Res 2023;43:2831-2840.
PMID: 37247885
|
|
|
|